Company Information
USD
44.03
- (-0.2%)
NYSE:BMY, BRISTOL-MYERS SQUIBB COMPANY
Industry: Drug Manufacturers - General
End of Day: 17 May 2024 GMT-4
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
Address
Route 206 and Province Line Road
Princeton
Website
Classification
Sector
Healthcare
Industry Group
Drug Manufacturers
Industry
Drug Manufacturers - General
Key Executives
Mr. Phil Holzer
Controller/Senior VP
Mr. Derica W. Rice
Director
Mr. Gerald L. Storch
Director
Ms. Phyllis R. Yale
Director
Ms. Paula A. Price
Director
Mr. Peter J. Arduini
Director
Ms. Sandra Leung
General Counsel/Executive VP
Mr. David V. Elkins
CFO/Executive VP
Dr. Giovanni Caforio, M.D.
Chairman of the Board/Director
Mr. Christopher S. Boerner, PhD
CEO/Director
Dr. Julia A. Haller, M.D.
Director
Mr. Theodore R. Samuels
Director
Dr. Karen H. Vousden, PhD
Director
Dr. Robert M. Plenge
Executive VP/Other Corporate Officer/Other Executive Officer
Dr. Samit Hirawat, M.D.
Chief Medical Officer/Executive VP/Other Corporate Officer
Mr. Manuel Hidalgo Medina, M.D.,PhD
Director
Mr. Gregory Scott Meyers
Chief Technology Officer/Executive VP/Other Executive Officer
Ms. Karin Shanahan
Executive VP, Divisional
Mr. Deepak L. Bhatt, M.D.,M.P.H.
Director
Mr. Adam Lenkowsky
Executive VP/Other Executive Officer
Ms. Cari Gallman
Executive VP, Divisional
Ms. Lynelle Hoch
President, Divisional
Ms. Amanda Ahn Poole
Executive VP/Other Executive Officer
Ownership
Institution Holdings
Vanguard Group Inc
198,159,772 (9.799%)
BlackRock Inc
168,103,766 (8.313%)
JPMorgan Chase & Co
90,048,274 (4.453%)
State Street Corporation
89,446,206 (4.423%)
Vanguard Investments Australia Ltd
65,110,537 (3.220%)
BlackRock Fund Advisors
62,970,159 (3.114%)
Capital Research & Mgmt Co - Division 3
61,528,492 (3.043%)
Capital Research and Management Company
58,062,664 (2.871%)
Fidelity Management & Research Company LLC
54,415,326 (2.691%)
J.P. Morgan Investment Management, Inc.
48,767,941 (2.412%)
Individual Holdings
Dr. Giovanni Caforio, M.D.
367,495 (0.018%)
Ms. Sandra Leung
331,414 (0.016%)
Mr. David V. Elkins
168,612 (0.008%)
Mr. Christopher S. Boerner, PhD
82,672 (0.004%)
Dr. Samit Hirawat, M.D.
47,245 (0.002%)
Mr. Theodore R. Samuels
35,500 (0.002%)
Powell Ann Judge
27,868 (0.001%)
Ms. Karen Murphy Santiago
16,704 (0.001%)
Dr. Julia A. Haller, M.D.
13,619 (0.001%)
Mr. Phil Holzer
10,011 (0.001%)
Funds Holdings
Vanguard Total Stock Market Index Fund
63,960,574 (3.163%)
Vanguard US Total Market Shares ETF
63,960,574 (3.163%)
Vanguard Institutional 500 Index Trust
50,289,060 (2.487%)
Fidelity 500 Index Fund
24,158,190 (1.195%)
SPDR® S&P 500 ETF Trust
23,884,777 (1.181%)
iShares Core S&P 500 ETF
21,169,112 (1.047%)
JPM US Equity Income-Composite
17,319,546 (0.856%)
Vanguard Value Index Fund
16,912,306 (0.836%)
JPMorgan Equity Income Fund
16,678,380 (0.825%)
Health Care Select Sector SPDR® Fund
15,412,754 (0.762%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
